Biblio

Export 18 results:
Author Keyword Title [ Type(Asc)] Year
Filters: Author is Villemagne, Victor L  [Clear All Filters]
Journal Article
N. Krishnadas, Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., M Y Goh, A., Lamb, F., Bozinovski, S., Burnham, S. C., Robertson, J. S., Laws, S. M., Maruff, P., Masters, C. L., Villemagne, V. L., and Rowe, C. C., Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
T. Porter, Burnham, S. C., Milicic, L., Savage, G., Maruff, P., Lim, Y. Ying, Li, Q. - X., Ames, D., Masters, C. L., Rainey-Smith, S., Rowe, C. C., Salvado, O., Groth, D., Verdile, G., Villemagne, V. L., and Laws, S. M., Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study., J Alzheimers Dis, vol. 66, no. 3, pp. 1193-1211, 2018.
M. D. Zwan, Villemagne, V. L., Doré, V., Buckley, R., Bourgeat, P., Veljanoski, R., Salvado, O., Williams, R., Margison, L., Rembach, A., S Macaulay, L., Martins, R., Ames, D., van der Flier, W. M., Ellis, K. A., Scheltens, P., Masters, C. L., and Rowe, C. C., Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden., J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
B. M. Brown, Rainey-Smith, S. R., Doré, V., Peiffer, J. J., Burnham, S. C., Laws, S. M., Taddei, K., Ames, D., Masters, C. L., Rowe, C. C., Martins, R. N., and Villemagne, V. L., Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography., J Alzheimers Dis, vol. 63, no. 4, pp. 1299-1305, 2018.
A. Elias, Cummins, T., Tyrrell, R., Lamb, F., Doré, V., Williams, R., Rosenfeld, J. V., Hopwood, M., Villemagne, V. L., and Rowe, C. C., Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging., J Alzheimers Dis, vol. 66, no. 2, pp. 733-741, 2018.
S. Hani Mouss Nik, Porter, T., Newman, M., Bartlett, B., Khan, I., Sabale, M., Eccles, M., Woodfield, A., Groth, D., Doré, V., Villemagne, V. L., Masters, C. L., Martins, R. N., Laws, S. M., Lardelli, M., and Verdile, G., Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration., J Alzheimers Dis, vol. 80, no. 4, pp. 1479-1489, 2021.
C. Dang, Harrington, K. D., Lim, Y. Ying, Ames, D., Hassenstab, J., Laws, S. M., Yassi, N., Hickey, M., Rainey-Smith, S., Robertson, J., Sohrabi, H. R., Salvado, O., Weinborn, M., Villemagne, V. L., Rowe, C. C., Masters, C. L., and Maruff, P., Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults., J Alzheimers Dis, vol. 65, no. 4, pp. 1313-1325, 2018.
S. Pedrini, Hone, E., Gupta, V. B., James, I., Teimouri, E., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Rainey-Smith, S., Verdile, G., Sohrabi, H. R., Raida, M. R., Wenk, M. R., Taddei, K., Chatterjee, P., Martins, I., Laws, S. M., and Martins, R. N., Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance., J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
S. Ramanan, Flanagan, E., Leyton, C. E., Villemagne, V. L., Rowe, C. C., Hodges, J. R., and Hornberger, M., Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology., J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.
W. Khan, Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Lemaître, H., Nees, F., Paus, T., Pausova, Z., Rietschel, M., Smolka, M. N., Ströhle, A., Gallinat, J., Vellas, B., Soininen, H., Kloszewska, I., Tsolaki, M., Mecocci, P., Spenger, C., Villemagne, V. L., Masters, C. L., Muehlboeck, J. - S., Bäckman, L., Fratiglioni, L., Kalpouzos, G., Wahlund, L. - O., Schumann, G., Lovestone, S., Williams, S. C. R., Westman, E., and Simmons, A., A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease., J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
J. E. Baker, Lim, Y. Ying, Jaeger, J., Ames, D., Lautenschlager, N. T., Robertson, J., Pietrzak, R. H., Snyder, P. J., Villemagne, V. L., Rowe, C. C., Masters, C. L., and Maruff, P., Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease., J Alzheimers Dis, vol. 65, no. 3, pp. 977-988, 2018.
Y. Ying Lim, Williamson, R., Laws, S. M., Villemagne, V. L., Bourgeat, P., Fowler, C., Rainey-Smith, S., Salvado, O., Martins, R. N., Rowe, C. C., Masters, C. L., and Maruff, P., Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals., J Alzheimers Dis, vol. 58, no. 4, pp. 1293-1302, 2017.
J. D. Doecke, Rembach, A., Villemagne, V. L., Varghese, S., Rainey-Smith, S., Sarros, S., Evered, L. A., Fowler, C. J., Pertile, K. K., Rumble, R. L., Trounson, B., Taddei, K., Laws, S. M., S Macaulay, L., Bush, A. I., Ellis, K. A., Martins, R., Ames, D., Silbert, B., Vanderstichele, H., Masters, C. L., Darby, D. G., Li, Q. - X., and Collins, S., Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms., J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
Y. Xia, Yassi, N., Raniga, P., Bourgeat, P., Desmond, P., Doecke, J., Ames, D., Laws, S. M., Fowler, C., Rainey-Smith, S. R., Martins, R., Maruff, P., Villemagne, V. L., Masters, C. L., Rowe, C. C., Fripp, J., and Salvado, O., Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging., J Alzheimers Dis, vol. 78, no. 1, pp. 321-334, 2020.
W. M. A. D. Bino Fernando, Rainey-Smith, S. R., Gardener, S. L., Villemagne, V. L., Burnham, S. C., S Macaulay, L., Brown, B. M., Gupta, V. Bala, Sohrabi, H. R., Weinborn, M., Taddei, K., Laws, S. M., Goozee, K., Ames, D., Fowler, C., Maruff, P., Masters, C. L., Salvado, O., Rowe, C. C., and Martins, R. N., Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β., J Alzheimers Dis, vol. 61, no. 4, pp. 1589-1598, 2018.
S. Hollands, Lim, Y. Ying, Laws, S. M., Villemagne, V. L., Pietrzak, R. H., Harrington, K., Porter, T., Snyder, P., Ames, D., Fowler, C., Rainey-Smith, S. R., Martins, R. N., Salvado, O., Robertson, J., Rowe, C. C., Masters, C. L., and Maruff, P., APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults., J Alzheimers Dis, vol. 57, no. 2, 2017.
Q. - X. Li, Villemagne, V. L., Doecke, J. D., Rembach, A., Sarros, S., Varghese, S., McGlade, A., Laughton, K. M., Pertile, K. K., Fowler, C. J., Rumble, R. L., Trounson, B. O., Taddei, K., Rainey-Smith, S. R., Laws, S. M., Robertson, J. S., Evered, L. A., Silbert, B., Ellis, K. A., Rowe, C. C., S Macaulay, L., Darby, D., Martins, R. N., Ames, D., Masters, C. L., and Collins, S., Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study., J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
M. T. Fodero-Tavoletti, Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C. A., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G., Gong, S., Adlard, P. A., Barnham, K. J., Rowe, C. C., Masters, C. L., Kudo, Y., Cappai, R., Yanai, K., and Villemagne, V. L., 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease., Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.